Stay updated on Cabozantinib for NSCLC Brain Metastases Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib for NSCLC Brain Metastases Clinical Trial page.

Latest updates to the Cabozantinib for NSCLC Brain Metastases Clinical Trial page
- Check2 days agoChange DetectedThe page’s footer software/version indicator was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” with no associated changes to the underlying study information.SummaryDifference0.1%

- Check9 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check38 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0. No visible changes to the study details page or layout.SummaryDifference0.1%

- Check46 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. No user-facing changes to study details or page functionality are introduced.SummaryDifference0.1%

- Check60 days agoChange DetectedNo substantive content changes were detected. The page appears to have only visual/layout adjustments without altering study details.SummaryDifference0.1%

- Check74 days agoChange DetectedThe page now shows Revision: v3.4.2 and the older notices about funding and v3.4.1 have been removed; these are administrative updates that do not affect the trial’s content or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Cabozantinib for NSCLC Brain Metastases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib for NSCLC Brain Metastases Clinical Trial page.